GM Double Blind Study

//GM Double Blind Study

GM Double Blind Study

FDA 3B Cold Laser

FDA CLEARANCE

Dermatek ML830® has FDA clearance for devices under both the “NHN” and “ILY” classifications. The Dermatek ML830® was cleared by the FDA for treatment of carpal tunnel syndrome. This clearance followed a double-blind study conducted at General Motors.

1. The Microlight 830Ⓡ Laser is indicated for adjunctive use in providing temporary relief of hand and wrist pain associated with Carpal Tunnel Syndrome.

2. Temporary relief of minor muscle and joint pain, arthritis and muscle spasm; temporary relief of stiffness and promotion of muscle tissue relaxation; and temporary increase of local blood circulation.

Double Blind Study:

By |2019-06-11T12:35:31-04:00October 4th, 2017|carpal tunnel|0 Comments

About the Author:

Leave A Comment